Agency Information Collection Activities: Submission for OMB Review; Comment Request; Registration of Mortgage Loan Originators, 60448-60449 [2012-24277]
Download as PDF
<![CDATA[
60448
Federal Register / Vol. 77, No. 192 / Wednesday, October 3, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences Notice of Meeting
erowe on DSK2VPTVN1PROD with
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIEHS.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Environmental
Health Sciences, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIEHS.
Date: November 4–6, 2012.
Closed: November 4, 2012, 7 p.m. to 10
p.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: Doubletree Guest Suites, 2515
Meridian Parkway, Research Triangle Park,
NC 27713.
Open: November 5, 2012, 8:30 a.m. to
11:50 a.m.
Agenda: Scientific Presentations
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: November 5, 2012, 11:50 a.m. to
12:35 p.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: November 5, 2012, 1:30 p.m. to
2:30 p.m.
Agenda: Poster Session.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: November 5, 2012, 2:45 p.m. to
3:15 p.m.
VerDate Mar<15>2010
18:36 Oct 02, 2012
Jkt 229001
Agenda: To review and evaluate
programmatic and personnel issues.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Open: November 5, 2012, 3:15 p.m. to 4:55
p.m.
Agenda: Scientific Presentations.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: November 5, 2012, 5 p.m. to 5:30
p.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Closed: November 5, 2012, 7:30 p.m. to
9:30 p.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: Doubletree Guest Suites, 2515
Meridian Parkway, Research Triangle Park,
NC 27713.
Closed: November 6, 2012, 8:30 a.m. to
9:30 a.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: National Institute of Environmental
Health Sciences, Building 101, Rodbell
Auditorium, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Contact Person: William Schrader, Ph.D.,
Deputy Scientific Director, Division of
Intramural Research, National Institute of
Environmental Health Sciences, 111 T.W.
Alexander Drive, Suite 101, A214, Research
Triangle Park, NC 27709.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Subcommittee—D.
Date: November 2, 2012.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, 6C/Room 7,
Bethesda, MD 20892.
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An18C, Bethesda, MD
20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: September 27, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24252 Filed 10–2–12; 8:45 am]
BILLING CODE 4140–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Dated: _______September 27, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request;
Registration of Mortgage Loan
Originators
[FR Doc. 2012–24254 Filed 10–2–12; 8:45 am]
AGENCY:
BILLING CODE 4140–01–P
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Federal Deposit Insurance
Corporation (FDIC).
E:\FR\FM\03OCN1.SGM
03OCN1
Federal Register / Vol. 77, No. 192 / Wednesday, October 3, 2012 / Notices
Withdrawal of notice and
request for comment.
ACTION:
The FDIC is withdrawing the
Notice of Submission for OMB Review;
Comment Request; Registration of
Mortgage Loan Originators (3064–0171)
published in the Federal Register on
September 27, 2012 (77 FR 59397). The
September 27, 2012 publication was an
inadvertent duplication of the Notice of
Submission for OMB Review; Comment
Request; Registration of Mortgage Loan
Originators (3064–0171) published in
the Federal Register on September 26,
2012 (77 FR 59192).
SUMMARY:
Dated: September 27, 2012.
Federal Deposit Insurance Corporation.
Pamela Johnson,
Regulatory Editing Specialist.
[FR Doc. 2012–24277 Filed 10–2–12; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories and
Instrumented Initial Testing Facilities
Which Meet Minimum Standards To
Engage in Urine Drug Testing for
Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies Federal
agencies of the Laboratories and
Instrumented Initial Testing Facilities
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908);
September 30, 1997 (62 FR 51118);
April 13, 2004 (69 FR 19644); November
25, 2008 (73 FR 71858); December 10,
2008 (73 FR 75122); and on April 30,
2010 (75 FR 22809).
A notice listing all currently certified
Laboratories and Instrumented Initial
Testing Facilities (IITF) is published in
the Federal Register during the first
week of each month. If any Laboratory/
IITF’s certification is suspended or
revoked, the Laboratory/IITF will be
omitted from subsequent lists until such
time as it is restored to full certification
under the Mandatory Guidelines.
erowe on DSK2VPTVN1PROD with
SUMMARY:
VerDate Mar<15>2010
15:03 Oct 02, 2012
Jkt 229001
If any Laboratory/IITF has withdrawn
from the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://
www.workplace.samhsa.gov and https://
www.drugfreeworkplace.gov.
Mrs.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room 2–
1042, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were initially
developed in accordance with Executive
Order 12564 and section 503 of Public
Law 100–71. The ‘‘Mandatory
Guidelines for Federal Workplace Drug
Testing Programs’’, as amended in the
revisions listed above, requires strict
standards that Laboratories and
Instrumented Initial Testing Facilities
(IITF) must meet in order to conduct
drug and specimen validity tests on
urine specimens for Federal agencies.
To become certified, an applicant
Laboratory/IITF must undergo three
rounds of performance testing plus an
on-site inspection. To maintain that
certification, a Laboratory/IITF must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories and Instrumented Initial
Testing Facilities (IITF) in the applicant
stage of certification are not to be
considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A Laboratory/
IITF must have its letter of certification
from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met
minimum standards.
In accordance with the Mandatory
Guidelines dated November 25, 2008
(73 FR 71858), the following
Laboratories and Instrumented Initial
Testing Facilities (IITF) meet the
minimum standards to conduct drug
and specimen validity tests on urine
specimens:
FOR FURTHER INFORMATION CONTACT:
Instrumented Initial Testing Facilities
(IITF)
None.
Laboratories
ACL Laboratories, 8901 W. Lincoln Ave.,
West Allis, WI 53227, 414–328–7840/800–
877–7016 (Formerly: Bayshore Clinical
Laboratory).
ACM Medical Laboratory, Inc., 160 Elmgrove
Park, Rochester, NY 14624, 585–429–2264.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
60449
Advanced Toxicology Network, 3560 Air
Center Cove, Suite 101, Memphis, TN
38118, 901–794–5770/888–290–1150.
Aegis Analytical Laboratories, 345 Hill Ave.,
Nashville, TN 37210 615–255–2400
(Formerly: Aegis Sciences Corporation,
Aegis Analytical Laboratories, Inc.).
Alere Toxicology Services, 1111 Newton St.,
Gretna, LA 70053, 504–361–8989/800–
433–3823 (Formerly: Kroll Laboratory
Specialists, Inc., Laboratory Specialists,
Inc.).
Alere Toxicology Services, 450 Southlake
Blvd., Richmond, VA 23236, 804–378–
9130 (Formerly: Kroll Laboratory
Specialists, Inc., Scientific Testing
Laboratories, Inc.; Kroll Scientific Testing
Laboratories, Inc.).
Baptist Medical Center—Toxicology
Laboratory, 11401 I–30, Little Rock, AR
72209–7056, 501–202–2783 (Formerly:
Forensic Toxicology Laboratory Baptist
Medical Center).
Clinical Reference Lab, 8433 Quivira Road,
Lenexa, KS 66215–2802, 800–445–6917.
Doctors Laboratory, Inc., 2906 Julia Drive,
Valdosta, GA 31602, 229–671–2281.
DrugScan, Inc., P.O. Box 2969, 1119 Mearns
Road, Warminster, PA 18974, 215–674–
9310.
ElSohly Laboratories, Inc., 5 Industrial Park
Drive, Oxford, MS 38655, 662–236–2609.
Gamma-Dynacare Medical Laboratories*, A
Division of the Gamma-Dynacare
Laboratory Partnership, 245 Pall Mall
Street, London, ONT, Canada N6A 1P4,
519–679–1630.
Laboratory Corporation of America Holdings,
7207 N. Gessner Road, Houston, TX 77040,
713–856–8288/800–800–2387.
Laboratory Corporation of America Holdings,
69 First Ave., Raritan, NJ 08869, 908–526–
2400/800–437–4986 (Formerly: Roche
Biomedical Laboratories, Inc.).
Laboratory Corporation of America Holdings,
1904 Alexander Drive, Research Triangle
Park, NC 27709, 919–572–6900/800–833–
3984 (Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of Roche
Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A Member
of the Roche Group).
Laboratory Corporation of America Holdings,
1120 Main Street, Southaven, MS 38671,
866–827–8042/800–233–6339 (Formerly:
LabCorp Occupational Testing Services,
Inc.; MedExpress/National Laboratory
Center).
LabOne, Inc. d/b/a Quest Diagnostics, 10101
Renner Blvd., Lenexa, KS 66219, 913–888–
3927/800–873–8845 (Formerly: Quest
Diagnostics Incorporated; LabOne, Inc.;
Center for Laboratory Services, a Division
of LabOne, Inc.,).
Maxxam Analytics*, 6740 Campobello Road,
Mississauga, ON, Canada L5N 2L8, 905–
817–5700 (Formerly: Maxxam Analytics
Inc., NOVAMANN (Ontario), Inc.).
MedTox Laboratories, Inc., 402 W. County
Road D, St. Paul, MN 55112, 651–636–
7466/800–832–3244.
MetroLab-Legacy Laboratory Services, 1225
NE 2nd Ave., Portland, OR 97232, 503–
413–5295/800–950–5295.
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 77, Number 192 (Wednesday, October 3, 2012)]
[Notices]
[Pages 60448-60449]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24277]
=======================================================================
-----------------------------------------------------------------------
FEDERAL DEPOSIT INSURANCE CORPORATION
Agency Information Collection Activities: Submission for OMB
Review; Comment Request; Registration of Mortgage Loan Originators
AGENCY: Federal Deposit Insurance Corporation (FDIC).
[[Page 60449]]
ACTION: Withdrawal of notice and request for comment.
-----------------------------------------------------------------------
SUMMARY: The FDIC is withdrawing the Notice of Submission for OMB
Review; Comment Request; Registration of Mortgage Loan Originators
(3064-0171) published in the Federal Register on September 27, 2012 (77
FR 59397). The September 27, 2012 publication was an inadvertent
duplication of the Notice of Submission for OMB Review; Comment
Request; Registration of Mortgage Loan Originators (3064-0171)
published in the Federal Register on September 26, 2012 (77 FR 59192).
Dated: September 27, 2012.
Federal Deposit Insurance Corporation.
Pamela Johnson,
Regulatory Editing Specialist.
[FR Doc. 2012-24277 Filed 10-2-12; 8:45 am]
BILLING CODE 6714-01-P
